Wildcat Capital Management LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Wildcat Capital Management LLC
CRD #162178
SEC #801-76510
CIK #0001582384
AUM 4,083.6 M (2026-05-12)
Employees 13 (100% Investors, 0% Brokers)
Fees
Minimum
Phone212-468-5100
Address888 7th Avenue
New York, NY 10106
Source [IAPD] [EDGAR] [Website] [LinkedIn]
Total AUM ($B)
5.04.03.02.01.00.02010201520212027
Fees and Compensation — Form ADV Part 2A (3/30/2026) [Brochure]
ITEM 5 – FEES AND COMPENSATION

Advisory Fees

Wildcat charges fees and expenses, pursuant to the Organizational Documents between Wildcat
and Clients. Unless otherwise specified in the Organizational Documents, Clients will generally
pay Wildcat an asset-based management fee (“Base Fee”), a performance-based fee or allocation
(“Performance Fee”) and/or Carried Interest (defined below) as set forth in the Organizational
Documents of the Client. The Base Fee and other fees and distributions described herein are
generally subject to modification, waiver or reduction by Wildcat in its sole discretion, both
voluntarily and on a negotiated basis with selected investors via side letter and other arrangements,
which generally will not be disclosed to other investors in the same Client, but Wildcat, in its sole
discretion, may elect to do so from time to time. The fee structures described herein may be
modified from time to time.

Base Fee. The Base Fee for a Client is typically calculated quarterly as a percentage of certain
assets under management plus cash, contributed capital associated with the Client’s aggregate
investment(s) in portfolio companies and/or remaining invested capital with respect to such Client
and is paid quarterly in advance and, with respect to certain Clients is subject to a periodic
reconciliation for under-payments by such Clients (and, in certain instances, over-payments by
such Client) based on the ultimate value of the fee base for such prior period. If an advisory
relationship with any Client is terminated during any calendar quarter, then a pro rata portion of
the prepaid Base Fee in respect of such quarter will typically be returned to the Client. The fee
structures described herein may be modified from time to time and Base Fees, Performance Fees
and Carried Interest may differ from one Client to another. Base Fees are expected to be payable
during any term extensions.

On a date specified in the Organizational Documents of certain Clients (the “Stepdown Date”), the
Base Fee may decrease and thereafter be calculated based using various methodologies such as,
the amount of remaining invested capital associated with the Client’s investment(s) in portfolio
companies that remain unrealized or with respect to which the Client has not completely disposed
of its interest (a complete disposition, each a “Disposition”) or have not been permanently written-
off. Because Base Fees with respect to certain Clients are calculated based on remaining invested
capital following the Stepdown Date, the Organizational Documents do not require any reduction
or refund of Base Fees following a write-off, or a decrease (including a significant decrease) in
fair value of an investment, or any partial realization, dividend, distribution (including those
arising from dividend recapitalizations), reorganization, restructuring, roll-over investment, or
similar transactions where the Client has not completely disposed of its interest in the portfolio
company, even if the value of the Client’s interest has been reduced (including materially reduced)
(each a “Recap Distribution”). As a result, the Base Fees generally will not track changes in the
fair value of any individual investment or of a Client. The Organizational Documents generally do
not provide for the reimbursement or refund of Base Fees in the event of Dispositions occurring
mid–calculation period.

Other Fees (as defined below, and which include but are not limited to transaction fees) and other
fees, costs and expenses allocated to a portfolio company at the time of investment (collectively,

“Capitalized Costs”) are generally capitalized into the amount of remaining invested capital with
respect to such portfolio company. Accordingly, where the Base Fee base post-Stepdown Date is
based on remaining invested capital, such base will include the value of such Capitalized Costs,
including such those payable or reimbursable to Wildcat and its affiliates. This would increase the
amount of Base Fees paid to Wildcat. Such increase is in addition to the Other Fees paid to Wildcat
and/or its affiliates.

Performance Fee. Performance Fees are generally calculated annually as a percentage of net
profits (realized or unrealized) attributable to the Client’s relevant assets and in accordance with
the Organizational Documents of such Client. Other performance allocations, interests or fees can
be agreed to by each Client. Performance Fees accrue throughout the year and are typically
allocated on the last day of the year (or earlier in the case of a termination or redemption) and
deducted from a Client’s assets and not billed separately.

Specific details about Base Fees and Performance Fees (or allocations) payable by a Client are set
out in the Organizational Documents of the relevant Client. For certain Clients, a client
representative (a “Client Representative”) designated by those Clients pursuant to the investment
management agreement among those Clients and Wildcat is responsible for appropriate allocation
of the respective amounts amongst such Clients.

Certain Clients may also pay Carried Interest. With respect to certain Clients a portion of the profits
or distributions of each such Client is distributed to an affiliate of Wildcat (which, for the
avoidance of doubt, may serve as a general partner, managing member, manager, special member,
special limited partner or similar entity (each, an “Affiliate”), if any, as “carried interest” (the
“Carried Interest”). Each such Affiliate that is entitled to Carried Interest is a related person of
Wildcat. Carried Interest paid by a Client is indirectly borne by investors in such Client. Certain
Clients and investors in such Clients (including Adviser Investors (as defined below)) may incur
lower or no Carried Interest. Specific detail about Carried Interest payable by Clients are set forth
in the Organizational Documents of the relevant Client. Please see Item 6 below regarding Carried
...
Account Minimums and Types of Clients — Form ADV Part 2A (3/30/2026) [Brochure]
ITEM 7 – TYPES OF CLIENTS

Clients are a person who is: (i) an “accredited investor” (as defined in Rule 501 under the Securities
Act of 1933) and (ii) a person who is a “qualified purchaser” (as defined in Section 2(a)(51) of the
Investment Company Act of 1940, as amended). If a Client is unable to meet the qualified
purchaser standard, such Client will be at least a “qualified client” within the meaning of Section
205(a)(1) of the Investment Advisers Act of 1940, as amended (“Advisers Act”).

Wildcat does not have a minimum investment amount but may, in the future, establish such
minimum investment amounts.
Sector Form 13F Holdings Value ($M)
Frontier Group Holdings Inc 99.1
Allogene Therapeutics Inc 7.1
 
 
 
 
 
 
 
 
 
Holdings by Sector ($M)
90072054036018002015201920232027
Type Form D Funds Date Sold AUM
PE JAVA Co-Investment I LP [2026-03-30] 30.5 M
Filed 2025-09-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Emerald Co-Investment A LP [2025-03-31] 82.7 M
Filed 2024-07-19 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE Wildcat Groff Co-Invest LP [2024-03-28] 8.6 M
Filed 2023-10-24 (D) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose
PE WPEP Milan Holdings II LP [2024-03-28] 4.6 M 5.1 M
Offered $4,600,000 · Filed 2023-06-09 (D) · Exemption 506(b), 3(c), 3(c)(7) · Duration One year or less · Revenue Decline to Disclose
Other 828061 2020-03-30 0.0 M
Other 828083 2020-03-30 25.1 M
PE 819694 2017-05-24 9.6 M
Other B02139 2015-03-31 30.1 M
Other B02140 2015-03-31 6.2 M
HF Wildcat - Liquid Alpha LLC 2013-03-28 26.5 M
View All
AUM Breakdown Accounts AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals) 0 0.0
(b) Individuals (high net worth individuals) 0 0.0
(c) Banking or thrift institutions 0 0.0
(d) Investment companies 0 0.0
(e) Business development companies 0 0.0
(f) Pooled investment vehicles 5 4.1
(g) Pension and profit sharing plans 0 0.0
(h) Charitable organizations 0 0.0
(i) State or municipal government entities 0 0.0
(j) Other investment advisers 0 0.0
(k) Insurance companies 0 0.0
(l) Sovereign wealth funds and foreign official institutions 0 0.0
(m) Corporations or other businesses not listed above 0 0.0
(n) Other 0 0.0
Total 5 4.1
By Discretionary
Discretionary 5 4.1
Non-Discretionary 0 0.0
Total 5 4.1
By Non-United States Persons
Non-United States Persons 0.0
United States Persons 4.1
Total 5 4.1
Form D Directors Role # Filings # Firms 2011 - 2026
Leonard Potter Executive Officer 25 5
Brian Rosenblatt Executive Officer 4 1
EDGAR Form CIK 2011 - 2026
13F-HR [0001582384]
3 [0001582384]
SC 13D [0001582384]
SC 13G [0001582384]
Form 13D/13G Filer Form 13D/13G Subject Filed
Wildcat Capital Management LLC Vicapsys Life Sciences Inc [2025-03-21]
Wildcat Capital Management LLC Silexion Therapeutics Corp [2024-08-22]
Wildcat Capital Management LLC Frontier Group Holdings Inc [2024-04-08]
Wildcat Capital Management LLC Skillz Inc [2020-12-28]
Wildcat Capital Management LLC UroGen Pharma Ltd [2019-10-04]
Wildcat Capital Management LLC Sorrento Therapeutics Inc [2017-02-14]
Wildcat Capital Management LLC Sorrento Therapeutics Inc [2016-04-18]
Wildcat Capital Management LLC Sorrento Therapeutics Inc [2016-04-18]
Firm Profile (Form ADV)
Discretionary AUM$1.3B
ServesInstitutional
Fund TypesHedge Fund, Private Equity
LEI254900CMZ08EKF0ZE827
Form 3/4/5 Subject 2011 - 2026
Vicapsys Life Sciences Inc
Wildcat Capital Management LLC
Potter Leonard
Bonderman Family Limited Partnership
Silexion Therapeutics Corp
Frontier Group Holdings Inc
Comparable Firms State AUM
Tinicum Incorporated
NY 4,228.0 M
Prophet Capital Asset Management LP
TX 4,200.0 M
Castleknight Management LP
NY 4,103.8 M
Fundamental Advisors LP
NY 4,086.4 M
Hudson Structured Capital Management Ltd
CT 4,028.4 M
Glade Brook Capital Partners LLC
CT 3,955.0 M
Avenue Europe International Management LP
NY 3,912.4 M
Cyrus Capital Partners LP
NY 3,866.5 M
Tree Line Capital Partners LLC
CA 3,847.7 M
Cormorant Asset Management LP
MA 3,838.6 M
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com